Omeros (OMER) Shareholder's Equity Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.18% |
| Dec 31, 2025 | -0.08% |
| Sep 30, 2025 | -20.35% |
| Jun 30, 2025 | -7.24% |
| Mar 31, 2025 | -10.12% |
| Dec 31, 2024 | -10.87% |
| Sep 30, 2024 | -1.96% |
| Jun 30, 2024 | 0.89% |
| Mar 31, 2024 | 10.03% |
| Dec 31, 2023 | 24.25% |
| Sep 30, 2023 | 30.97% |
| Jun 30, 2023 | 18.78% |
| Mar 31, 2023 | 31.15% |
| Dec 31, 2022 | 100.56% |
| Sep 30, 2022 | -47.70% |
| Jun 30, 2022 | 9.83% |
| Mar 31, 2022 | 36.61% |
| Dec 31, 2021 | 21.38% |
| Sep 30, 2021 | -63.08% |
| Jun 30, 2021 | -38.12% |
| Mar 31, 2021 | -40.36% |
| Dec 31, 2020 | -35.71% |
| Sep 30, 2020 | -57.52% |
| Jun 30, 2020 | -86.12% |
| Mar 31, 2020 | -51.71% |
| Dec 31, 2019 | -20.65% |
| Sep 30, 2019 | -39.39% |
| Jun 30, 2019 | -65.13% |
| Mar 31, 2019 | -90.70% |
| Dec 31, 2018 | -40.36% |
| Sep 30, 2018 | -30.08% |
| Jun 30, 2018 | -35.65% |
| Mar 31, 2018 | -12.99% |
| Dec 31, 2017 | 15.50% |
| Sep 30, 2017 | 67.62% |
| Jun 30, 2017 | -21.71% |
| Mar 31, 2017 | -30.56% |
| Dec 31, 2016 | -46.47% |
| Sep 30, 2016 | -49.97% |
| Jun 30, 2016 | -47.12% |
| Dec 31, 2015 | -26.83% |